Letter from the Editor in Chief

DOI: 10.19102/icrm.2020.110805

MOUSSA MANSOUR, MD, FHRS, FACC

Efficacy of Implantable Cardioverter-defibrillators for Secondary Prevention of Sudden Cardiac Death in Patients with End-stage Renal Disease

DOI: 10.19102/icrm.2020.110803

TAYLOR PAYNE, MD,¹ JENNIFER WALLER, PhD,² MUFADDAL KHEDA, MD,¹ N. STANLEY NAHMAN, Jr., MD,¹ JOYCE MAALOUF, MS,¹ AARON GOPAL, MD,¹ and HAITHAM HREIBE, MD¹

¹Department of Medicine, Medical College of Georgia at Augusta University, Augusta, GA, USA

²Department of Population Health, Medicine Medical College of Georgia at Augusta University, Augusta, GA, USA

What Coronavirus Disease 2019 Has Taught Us About Modern Electrophysiology Practice

DOI: 10.19102/icrm.2020.110801

DANIEL SOHINKI, MD, MSc, FACC, FHRS¹ and ADAM E. BERMAN, MD, MSc, MPH, FHRS^1,2

¹Division of Adult Cardiology, Medical College of Georgia, Augusta, GA, USA

²Division of Pediatric Cardiology, Medical College of Georgia, Augusta, GA, USA

Engaging Patients in Atrial Fibrillation Management via Digital Health Technology: The Impact of Tailored Messaging

DOI: 10.19102/icrm.2020.110802

TAMMY TOSCOS, PhD,¹ AMANDA COUPE, BA,¹ SHAUNA WAGNER, RN, BSN,¹ RYAN AHMED, MS,¹ AMELIA ROEBUCK, BS,¹ MINDY FLANAGAN, PhD,¹ MICHELLE DROUIN, PhD,¹ and MICHAEL MIRRO, MD, FACC, FHRS, FAHA, FACP¹

¹Parkview Mirro Center for Research and Innovation, Health Services and Informatics Research Department, Parkview Health, Fort Wayne, IN 46845, USA

Cardiovascular Considerations in Coronavirus Disease 2019 with a Special Focus on Arrhythmia

DOI: 10.19102/icrm.2020.110804

TIFFANY Y. HU, MD,¹ JUSTIN Z. LEE, MBBS,¹ and SAMUEL J. ASIRVATHAM, MD^1,2

¹Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA

²Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA